Pseudoachondroplasia
Edit

Pseudoachondroplasia is an inherited disorder of bone growth.

genetic conditions

1. Introduction

It was once thought to be related to another disorder of bone growth called achondroplasia, but without that disorder's characteristic facial features. More research has demonstrated that pseudoachondroplasia is a separate disorder.

All people with pseudoachondroplasia have short stature. The average height of adult males with this condition is 120 centimeters (3 feet, 11 inches), and the average height of adult females is 116 centimeters (3 feet, 9 inches). Individuals with pseudoachondroplasia are not unusually short at birth; by the age of two, their growth rate falls below the standard growth curve.

Other characteristic features of pseudoachondroplasia include short arms and legs; a waddling walk; joint pain in childhood that progresses to a joint disease known as osteoarthritis; an unusually large range of joint movement (hyperextensibility) in the hands, knees, and ankles; and a limited range of motion at the elbows and hips. Some people with pseudoachondroplasia have legs that turn outward or inward (valgus or varus deformity). Sometimes, one leg turns outward and the other inward, which is called windswept deformity. Some affected individuals have a spine that curves to the side (scoliosis) or an abnormally curved lower back (lordosis). People with pseudoachondroplasia have normal facial features, head size, and intelligence.

2. Frequency

The exact prevalence of pseudoachondroplasia is unknown; it is estimated to occur in 1 in 30,000 individuals.

3. Causes

Mutations in the COMP gene cause pseudoachondroplasia. This gene provides instructions for making a protein that is essential for the normal development of cartilage and for its conversion to bone. Cartilage is a tough, flexible tissue that makes up much of the skeleton during early development. Most cartilage is later converted to bone, except for the cartilage that continues to cover and protect the ends of bones and is present in the nose and external ears.

The COMP protein is normally found in the spaces between cartilage-forming cells called chondrocytes, where it interacts with other proteins. COMP gene mutations result in the production of an abnormal COMP protein that cannot be transported out of the cell. The abnormal protein builds up inside the chondrocyte and ultimately leads to early cell death. Early death of the chondrocytes prevents normal bone growth and causes the short stature and bone abnormalities seen in pseudoachondroplasia.

The Gene Associated with Pseudoachondroplasia

  • COMP

4. Inheritance

Pseudoachondroplasia is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

In some cases, an affected person inherits the mutation from one affected parent. Most cases result from new mutations in the gene and occur in people with no history of the disorder in their family.

5. Other Names for This Condition

  • PSACH

  • pseudoachondroplastic dysplasia

  • pseudoachondroplastic spondyloepiphyseal dysplasia syndrome

References

  1. Briggs MD, Wright MJ. Pseudoachondroplasia. 2004 Aug 20 [updated 2018 Aug 16].In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington,Seattle; 1993-2020. Available from http://www.ncbi.nlm.nih.gov/books/NBK1487/
  2. Cao LH, Wang LB, Wang SS, Ma HW, Ji CY, Luo Y. Identification of novel andrecurrent mutations in the calcium binding type III repeats of cartilageoligomeric matrix protein in patients with pseudoachondroplasia. Genet Mol Res.2011 May 24;10(2):955-63. doi: 10.4238/vol10-2gmr1111.
  3. Hecht JT, Makitie O, Hayes E, Haynes R, Susic M, Montufar-Solis D, Duke PJ,Cole WG. Chondrocyte cell death and intracellular distribution of COMP and typeIX collagen in the pseudoachondroplasia growth plate. J Orthop Res. 2004Jul;22(4):759-67.
  4. Jackson GC, Mittaz-Crettol L, Taylor JA, Mortier GR, Spranger J, Zabel B, LeMerrer M, Cormier-Daire V, Hall CM, Offiah A, Wright MJ, Savarirayan R, NishimuraG, Ramsden SC, Elles R, Bonafe L, Superti-Furga A, Unger S, Zankl A, Briggs MD.Pseudoachondroplasia and multiple epiphyseal dysplasia: a 7-year comprehensiveanalysis of the known disease genes identify novel and recurrent mutations andprovides an accurate assessment of their relative contribution. Hum Mutat. 2012Jan;33(1):144-57. doi: 10.1002/humu.21611.
  5. Posey KL, Yang Y, Veerisetty AC, Sharan SK, Hecht JT. Model systems forstudying skeletal dysplasias caused by TSP-5/COMP mutations. Cell Mol Life Sci.2008 Mar;65(5):687-99. doi: 10.1007/s00018-007-7485-0. Review.
More
Related Content
This study evaluates the current scope of smart technology applications that support aging in place and identifies potential avenues for future research. The global demographic shift towards an aging population has intensified interest in technologies that enable older adults to maintain independence and quality of life within their homes. We conducted a systematic review of the scientific literature from Web of Science, PubMed, and ProQuest, identifying 44 smart technologies across 32 publications. These technologies were classified into three categories: nonmobile technologies for individual monitoring, nonmobile technologies for home environment monitoring, and wearable technologies for health and activity tracking. Notably, the research in this area has grown significantly since 2018; yet, notable gaps persist, particularly within the traditional disciplines related to aging and in the use of quantitative methodologies. This emerging field presents substantial opportunities for interdisciplinary research and methodological advancement, highlighting the need for well-developed research strategies to support the effective integration of smart technology in aging in place.
Keywords: smart technologies; healthy; application; aging in place; review
Discover when surgery is necessary for bone fractures, including key factors and treatment options for optimal recovery.
Keywords: imaging services for orthopedic injuries; diagnosing bone fractures through a CT scan
Background and Objectives: Wolfram syndrome type 1 (OMIM# 222300; ORPHAcode 3463) is an extremely rare autosomal recessive syndrome with a 25% recurrence risk in children. It is characterized by the presence of juvenile-onset diabetes mellitus (DM), progressive optic atrophy (OA), diabetes insipidus (DI), and sensorineural deafness (D), often referred to by the acronym DIDMOAD. It is a severe neurodegenerative disease with a life expectancy of 39 years, with death occurring due to cerebral atrophy. For a positive diagnosis, the presence of diabetes mellitus and optic nerve atrophy is sufficient. The disease occurs because of pathogenic variants in the WFS1 gene. The aim of this article is to present a case report of Wolfram Syndrome Type I, alongside a review of genetic variants, clinical manifestations, diagnosis, therapy, and long-term management. Emphasizing the importance of early diagnosis and a multidisciplinary approach, the study aims to enhance understanding and improve outcomes for patients with this complex syndrome. Materials and Methods: A case of a 28-year-old patient diagnosed with DM at the age of 6 and with progressive optic atrophy at 26 years old is presented. Molecular diagnosis revealed the presence of a heterozygous nonsense variant WFS1 c.1943G>A (p.Trp648*), and a heterozygous missense variant WFS1 c.1675G>C (p.Ala559Pro). Results: The molecular diagnosis of the patient confirmed the presence of a heterozygous nonsense variant and a heterozygous missense variant in the WFS1 gene, correlating with the clinical presentation of Wolfram syndrome type 1. Both allelic variants found in our patient have been previously described in other patients, whilst this combination has not been described before. Conclusions: This case report and review underscores the critical role of early recognition and diagnosis in Wolfram syndrome, facilitated by genetic testing. By identifying pathogenic variants in the WFS1 gene, genetic testing not only confirms diagnosis but also guides clinical management and informs genetic counseling for affected families. Timely intervention based on genetic insights can potentially reduce the progressive multisystem manifestations of the syndrome, thereby improving the quality of life and outcomes for patients.
Keywords: Wolfram syndrome type 1; optic atrophy; insulin-requiring diabetes mellitus; sensorineural deafness
Clinical features of Morgellons disease. A, MD patient back showing lesions covering entire surface, including areas out of patient’s reach. B, Back of patient with scratching-induced lesions showing distribution limited to patient’s reach. C, Multicolored fibers embedded in skin callus from MD Patient 2 (100x). 
Keywords: bacteria; Borreliella burgdorferi
Vitamin D is a secosteroid hormone essential for calcium homeostasis and skeletal health, but established evidence highlights its significant roles also in muscle health and in the modulation of immune response. This review aims to explore the impact of impaired vitamin D status on outcomes of muscle function and involvement in inflammatory and autoimmune rheumatic diseases damaging the skeletal muscle efficiency both with direct immune-mediated mechanisms and indirect processes such as sarcopenia. Altered serum vitamin D status is commonly observed in inflammatory and autoimmune rheumatic diseases and seems to be associated with adverse muscle health outcomes. While maintaining adequate serum vitamin D concentrations may confer muscle-protective effects, further research is needed to confirm these findings and establish optimal supplementation strategies to obtain a safe and efficient serum threshold.
Keywords: vitamin D; connective tissue diseases; myositis; autoimmune rheumatic diseases
Information
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 649
Entry Collection: MedlinePlus
Revisions: 2 times (View History)
Update Date: 24 Dec 2020
Video Production Service